Effect Of Hot Water Foot Bath Applied İn The Early Period After Cesarean Section On Pain, Fatigue And Gas Release
NCT ID: NCT05609838
Last Updated: 2022-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2021-12-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Hot Water After Cesarean Section
NCT05560347
The Effect of Foot Reflexology After Cesarean Section
NCT05268328
The Effect of Coffee and Hot Water on Gastroıntestınal Functıons
NCT05980975
Maternal Body Temperature in Caesarean Section
NCT06725407
Perioperative Warming Measures in Cesarean Delivery
NCT05015582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
A 15 minutes hot water foot bath was applied to the experimental group patients 3 hours after the cesarean section.Data collection tools were applied at the 5th minute, 1st hour and 2nd hour after the hot water footbath and the gas output was questioned.
Hot water foot bath
A 15 minutes hot water foot bath was applied to the experimental group patients 3 hours after the cesarean section.
Control Group
The control group was given routine post-cesarean care without any intervention and data collection tools were applied at the same time as the experimental group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hot water foot bath
A 15 minutes hot water foot bath was applied to the experimental group patients 3 hours after the cesarean section.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years old
* No history of any medical illness
* Receiving spinal anesthesia in cesarean section
* No complications during or after cesarean section
* Those who have not had any problems during pregnancy
* No mental handicap or perception problems and no communication difficulties
* Women who do not release gas before applying a hot water foot bath
Exclusion Criteria
* Gas-releasing before hot water footbath application
* sensory loss
* Wounds and/or lesions on their feet
* Those with vascular diseases
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Gaziantep
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oya KAPLAN
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oya KAPLAN, PhD Student
Role: PRINCIPAL_INVESTIGATOR
University of Gaziantep
Simge ZEYNELOĞLU, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Gaziantep
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziantep University
Gaziantep, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UGaziantep-SBF-OK-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.